These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 17382364)
1. Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo. Rossi SL; Fayzulin R; Dewsbury N; Bourne N; Mason PW Virology; 2007 Jul; 364(1):184-95. PubMed ID: 17382364 [TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146 [TBL] [Abstract][Full Text] [Related]
3. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. Rossi SL; Zhao Q; O'Donnell VK; Mason PW Virology; 2005 Jan; 331(2):457-70. PubMed ID: 15629788 [TBL] [Abstract][Full Text] [Related]
4. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. Liu WJ; Chen HB; Wang XJ; Huang H; Khromykh AA J Virol; 2004 Nov; 78(22):12225-35. PubMed ID: 15507609 [TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Shi PY; Tilgner M; Lo MK Virology; 2002 May; 296(2):219-33. PubMed ID: 12069521 [TBL] [Abstract][Full Text] [Related]
6. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication. Ong SP; Choo BG; Chu JJ; Ng ML Antiviral Res; 2006 Dec; 72(3):216-23. PubMed ID: 16870272 [TBL] [Abstract][Full Text] [Related]
7. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Wicker JA; Whiteman MC; Beasley DW; Davis CT; Zhang S; Schneider BS; Higgs S; Kinney RM; Barrett AD Virology; 2006 Jun; 349(2):245-53. PubMed ID: 16624366 [TBL] [Abstract][Full Text] [Related]
8. RNA elements within the 5' untranslated region of the West Nile virus genome are critical for RNA synthesis and virus replication. Li XF; Jiang T; Yu XD; Deng YQ; Zhao H; Zhu QY; Qin ED; Qin CF J Gen Virol; 2010 May; 91(Pt 5):1218-23. PubMed ID: 20016034 [TBL] [Abstract][Full Text] [Related]
9. West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Scholle F; Mason PW Virology; 2005 Nov; 342(1):77-87. PubMed ID: 16111732 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines. Fayzulin R; Scholle F; Petrakova O; Frolov I; Mason PW Virology; 2006 Jul; 351(1):196-209. PubMed ID: 16647099 [TBL] [Abstract][Full Text] [Related]
11. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Ramanathan MP; Chambers JA; Pankhong P; Chattergoon M; Attatippaholkun W; Dang K; Shah N; Weiner DB Virology; 2006 Feb; 345(1):56-72. PubMed ID: 16243374 [TBL] [Abstract][Full Text] [Related]
12. Biological properties of chimeric West Nile viruses. Borisevich V; Seregin A; Nistler R; Mutabazi D; Yamshchikov V Virology; 2006 Jun; 349(2):371-81. PubMed ID: 16545851 [TBL] [Abstract][Full Text] [Related]
13. Genetic systems of West Nile virus and their potential applications. Shi PY Curr Opin Investig Drugs; 2003 Aug; 4(8):959-65. PubMed ID: 14508880 [TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of West Nile virus containing a complete 3'CSI RNA deletion. Zhang B; Dong H; Ye H; Tilgner M; Shi PY Virology; 2010 Dec; 408(2):138-45. PubMed ID: 20965539 [TBL] [Abstract][Full Text] [Related]
15. West Nile virus genome cyclization and RNA replication require two pairs of long-distance RNA interactions. Zhang B; Dong H; Stein DA; Iversen PL; Shi PY Virology; 2008 Mar; 373(1):1-13. PubMed ID: 18258275 [TBL] [Abstract][Full Text] [Related]
16. Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds. Alcaraz-Estrada SL; Reichert ED; Padmanabhan R Methods Mol Biol; 2013; 1030():283-99. PubMed ID: 23821276 [TBL] [Abstract][Full Text] [Related]
17. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. Abe K; Ikeda M; Dansako H; Naka K; Kato N Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465 [TBL] [Abstract][Full Text] [Related]
18. Terminal structures of West Nile virus genomic RNA and their interactions with viral NS5 protein. Dong H; Zhang B; Shi PY Virology; 2008 Nov; 381(1):123-35. PubMed ID: 18799181 [TBL] [Abstract][Full Text] [Related]
19. A PCR-based protocol for generating West Nile virus replicons. Maeda J; Takagi H; Hashimoto S; Kurane I; Maeda A J Virol Methods; 2008 Mar; 148(1-2):244-52. PubMed ID: 18242719 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. Liu WJ; Wang XJ; Mokhonov VV; Shi PY; Randall R; Khromykh AA J Virol; 2005 Feb; 79(3):1934-42. PubMed ID: 15650219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]